Persistent URL of this record https://hdl.handle.net/1887/121517
In Collections
This item can be found in the following collections:
An AXL-specific antibody-drug conjugate shows preclinical anti-tumor activity in non-small cell lung cancer, including EGFR-inhibitor resistant NSCLC
- All authors
- Koopman, L.A.; Janmaat, M.L.; Jacobsen, K.; Terp, M.G.; Gresnigt-van den Heuvel, E.; Forssman, U.; Lingnau, A.; Parren, P.W.; Ditzel, H.; Breij, E.C.
- Date
- 2018-07-01
- Title of host publication
- Cancer Research
- Volume
- 78
- Issue
- 13